GeneDx Reports Second Quarter 2026 Financial Results
Business Wire•03/08/2026•16:05 ET
0
Whiz Insights
* Reported second quarter 2026 revenue of $114.4 million, including $100.3 million in exome and genome revenue
Reported exome and genome volume growth of 32% year-over-year
Get started
Create a free account to read the full story.